ROIVW (Roivant Sciences) PB Ratio: (As of Jun. 27, 2026)


ROIVW Roivant Sciences Ltd ROIVW
55 GF Score
Price $2.75
! 7 Warning Signs
View Full Analysis

What is Roivant Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Roivant Sciences's share price is $2.75. Roivant Sciences's Book Value per Share for the quarter that ended in Mar. 2026 was $0.00. Hence, Roivant Sciences's PB Ratio of today is .

Warning Sign:

Roivant Sciences Ltd stock PB Ratio (=5.42) is close to 2-year high of 5.42.

The historical rank and industry rank for Roivant Sciences's PB Ratio or its related term are showing as below:

ROIVW' s PB Ratio Range Over the Past 10 Years
Min: 1.31   Med: 2.36   Max: 10.61
Current: 5.42

During the past 6 years, Roivant Sciences's highest PB Ratio was 10.61. The lowest was 1.31. And the median was 2.36.

ROIVW's PB Ratio is ranked worse than
73.05% of 1232 companies
in the Biotechnology industry
Industry Median: 2.8 vs ROIVW: 5.42

During the past 12 months, Roivant Sciences's average Book Value Per Share Growth Rate was -6.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 60.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 29.60% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Roivant Sciences was 60.40% per year. The lowest was 41.30% per year. And the median was 41.40% per year.

Back to Basics: PB Ratio


Roivant Sciences  (NAS:ROIVW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Roivant Sciences PB Ratio Related Terms


Roivant Sciences PB Ratio Historical Data

* Premium members only.

The historical data trend for Roivant Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roivant Sciences PB Ratio Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Roivant Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROIVW vs INSM, INCY, BNTX: PB Ratio Comparison

For the Biotechnology subindustry, Roivant Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roivant Sciences PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's PB Ratio falls into.


ROIVW
55GF Score
Roivant Sciences Ltd ROIVW
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roivant Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Roivant Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=2.75/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Roivant Sciences Business Description

Other Exchanges ROIV:USA87S:Germany
Address 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
55GF Score

Get the complete analysis for ROIVW

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price